Ligne de temps
Nader Yatim
Médecin
25 nov. 2022
publication
Defective activation and regulation of type I interferon immunity is associated with increasing COVID-19 severity.
Lire plus01 déc. 2021
publication
Type I interferon response and vascular alteration in chilblain-like lesions during the COVID-19 outbreak.
Lire plus17 nov. 2021
publication
Severe COVID-19 is associated with hyperactivation of the alternative complement pathway.
Lire plus01 sept. 2021
publication
Distinct systemic and mucosal immune responses during acute SARS-CoV-2 infection.
Lire plus18 août 2021
01 août 2021
publication
Immune checkpoint inhibitors increase T cell immunity during SARS-CoV-2 infection.
Lire plus17 juil. 2021
04 juin 2021
publication
Regulation of the acetylcholine/α7nAChR anti-inflammatory pathway in COVID-19 patients.
Lire plus13 juil. 2020
publication
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients.
Lire plus27 mai 2020
publication
Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients.
Lire plus10 mai 2018
publication
Autophagy diminishes the early interferon-β response to influenza A virus resulting in differential expression of interferon-stimulated genes
Lire plus13 mars 2017
24 sept. 2015
publication
RIPK1 and NF-κB signaling in dying cells determines cross-priming of CD8+ T cells
Lire plus15 juin 2015
publication
Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy
Lire plus06 juin 2014
publication
RIPK1 both positively and negatively regulates RIPK3 oligomerization and necroptosis
Lire plus21 nov. 2013
publication
Widespread mitochondrial depletion via mitophagy does not compromise necroptosis
Lire plus28 oct. 2011
publication